Page last updated: 2024-09-03

panipenem-betamipron and Multiple Myeloma

panipenem-betamipron has been researched along with Multiple Myeloma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Horiike, S; Iwai, T; Kashima, K; Kobayashi, M; Misawa, S; Nakazawa, N; Ohkawara, Y; Okamoto, T; Sasai, Y; Tamura, A; Taniwaki, M; Tuda, S; Yokota, S1

Trials

1 trial(s) available for panipenem-betamipron and Multiple Myeloma

ArticleYear
[Clinical evaluation of panipenem/betamipron as a second line chemotherapy in severe infections associated with hematological disorders].
    The Japanese journal of antibiotics, 1998, Volume: 51, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Anemia, Aplastic; Bacterial Infections; beta-Alanine; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Leukemia; Lymphoma; Male; Middle Aged; Multiple Myeloma; Pneumonia; Pyelonephritis; Sepsis; Thienamycins; Treatment Outcome

1998